High-Content Screening and Computational Prediction Reveal Viral Genes That Suppress the Innate Immune Response

Tai L. Ng, Erika J. Olson, Tae Yeon Yoo, H. Sloane Weiss, Yukiye Koide, Peter D. Koch, Nathan Rollins, Pia Mach, Tobias Meisinger, Trenton Bricken, Timothy Z. Chang, Colin Molloy, Jérôme Zürcher, Roger L. Chang, Timothy J. Mitchison, John I. Glass, Debora S. Marks, Jeffrey C. Way, Pamela A. SilvermSystems 2022 · DOI

Abstract

Suppression of the host innate immune response is a critical aspect of viral replication. Upon infection, viruses may introduce one or more proteins that inhibit key immune pathways, such as the type I interferon pathway. However, the ability to predict and evaluate viral protein bioactivity on targeted pathways remains challenging and is typically done on a single virus/gene basis. Here, we present a medium-throughput high-content cell-based assay to reveal the immunosuppressive effects of viral proteins. To test the predictive power of our approach, we developed a library of 800 genes encoding known, predicted, and uncharacterized human viral genes. We find that previously known immune suppressors from numerous viral families such as Picornaviridae and Flaviviridae recorded positive responses. These include a number of viral proteases for which we further confirmed that innate immune suppression depends on protease activity. A class of predicted inhibitors encoded by Rhabdoviridae viruses was demonstrated to block nuclear transport, and several previously uncharacterized proteins from uncultivated viruses were shown to inhibit nuclear transport of the transcription factors NF-κB and IRF3. We propose that this pathway-based assay, together with early sequencing, gene synthesis, and viral infection studies, could partly serve as the basis for rapid in vitro characterization of novel viral proteins.

Introduction

When a virus infects a cell, the host’s innate immune system acts like a burglar alarm, triggering pathways such as the Type I Interferon response to halt viral replication and alert neighboring cells. To survive, viruses have evolved "immunosuppressive" proteins that disrupt these signaling pathways. While metagenomic sequencing is uncovering new viruses at an unprecedented rate, functional characterization of their proteins remains a significant bottleneck. Traditional "one-gene-at-a-time" research is too slow to keep up with emerging threats. There is a critical need for standardized, scalable assays that can rapidly link viral sequences to their immunosuppressive functions.

Methods

We developed a multipronged discovery pipeline combining bioinformatic prediction with high-content imaging.

Bioinformatic Library Construction

We curated a library of 800 viral genes using sequence similarity and domain analysis (Pfam). This library included 605 genes from 31 viral families and 195 genes from Coronaviridae. The collection encompassed known inhibitors (controls), predicted inhibitors, and 536 sequences with previously unannotated functions.

Bioinformatics pipeline and viral gene library composition

High-Content Screening (HCS) Assay

We utilized BJ-5ta human fibroblasts as a model system. To reduce background noise from transfected DNA, we used CRISPR to knock out the cGAS gene. This "silenced" the internal DNA-sensing machinery, allowing us to isolate the effects of viral proteins on specific external stimuli, such as cGAMP (STING pathway), poly(I:C) (RLR pathway), or IFNα (JAK-STAT pathway).

High-content screening assay for transcription factor translocation

Automated fluorescence microscopy was used to track the movement of key transcription factors (IRF3, NF-κB, and pSTAT1). In a normal immune response, these proteins translocate from the cytoplasm to the nucleus. Viral inhibitors are identified by their ability to trap these factors in the cytoplasm.

Results

The screen identified 79 stringent hits (p < 0.05) that significantly inhibited transcription factor translocation.

  • Pathway Specificity: Most viral proteins were specialists, often inhibiting IRF3 (the primary viral alarm) but not NF-κB (the general inflammatory alarm).
  • Validation of SARS-CoV-2: The assay identified Orf6 as a potent inhibitor of pSTAT1 and Nsp1 as a broad suppressor, validating the HCS approach against known high-profile pathogens.
  • Unmasking Understudied Viruses: We identified a novel immune suppressor in Torque Teno Virus (TTV), a common but poorly understood virus. We also found that Matrix (M) proteins from the Rhabdoviridae family act as "gatekeepers," physically blocking nuclear pores.
  • Protease Moonlighting: We confirmed that several viral proteases, such as the 3C protease from Salivirus A, inhibit IRF3 translocation through their proteolytic activity.

Discussion

By creating a "clean" experimental environment through cGAS knockout, we successfully developed a robust platform for identifying specific viral antagonists. This study demonstrates that high-content screening can rapidly characterize the "arsenal" of a virus, providing functional insights that complement genomic sequencing. While the study of isolated proteins in a single cell type has limitations—such as missing protein complex interactions or tissue-specific responses—this platform represents a practical step toward the early-stage evaluation of emerging and understudied viruses. Future work could deploy this tool as a "first response" mechanism during outbreaks, characterizing new viral proteins within weeks of genome sequencing.

Summary updated

Abstract

Suppression of the host innate immune response is a critical aspect of viral replication. Upon infection, viruses may introduce one or more proteins that inhibit key immune pathways, such as the type I interferon pathway. However, the ability to predict and evaluate viral protein bioactivity on targeted pathways remains challenging and is typically done on a single-virus or -gene basis. Here, we present a medium-throughput high-content cell-based assay to reveal the immunosuppressive effects of viral proteins. To test the predictive power of our approach, we developed a library of 800 genes encoding known, predicted, and uncharacterized human virus genes. We found that previously known immune suppressors from numerous viral families such as <i>Picornaviridae</i> and <i>Flaviviridae</i> recorded positive responses. These include a number of viral proteases for which we further confirmed that innate immune suppression depends on protease activity. A class of predicted inhibitors encoded by <i>Rhabdoviridae</i> viruses was demonstrated to block nuclear transport, and several previously uncharacterized proteins from uncultivated viruses were shown to inhibit nuclear transport of the transcription factors NF-κB and interferon regulatory factor 3 (IRF3). We propose that this pathway-based assay, together with early sequencing, gene synthesis, and viral infection studies, could partly serve as the basis for rapid <i>in vitro</i> characterization of novel viral proteins. <b>IMPORTANCE</b> Infectious diseases caused by viral pathogens exacerbate health care and economic burdens. Numerous viral biomolecules suppress the human innate immune system, enabling viruses to evade an immune response from the host. Despite our current understanding of viral replications and immune evasion, new viral proteins, including those encoded by uncultivated viruses or emerging viruses, are being unearthed at a rapid pace from large-scale sequencing and surveillance projects. The use of medium- and high-throughput functional assays to characterize immunosuppressive functions of viral proteins can advance our understanding of viral replication and possibly treatment of infections. In this study, we assembled a large viral-gene library from diverse viral families and developed a high-content assay to test for inhibition of innate immunity pathways. Our work expands the tools that can rapidly link sequence and protein function, representing a practical step toward early-stage evaluation of emerging and understudied viruses.
BibTeX
@inproceedings{ng2022high,
  author = {Tai L. Ng and Erika J. Olson and Tae Yeon Yoo and H. Sloane Weiss and Yukiye Koide and Peter D. Koch and Nathan Rollins and Pia Mach and Tobias Meisinger and Trenton Bricken and Timothy Z. Chang and Colin Molloy and Jérôme Zürcher and Roger L. Chang and Timothy J. Mitchison and John I. Glass and Debora S. Marks and Jeffrey C. Way and Pamela A. Silver},
  title = {{High-Content Screening and Computational Prediction Reveal Viral Genes That Suppress the Innate Immune Response}},
  booktitle = {mSystems},
  year = {2022},
  doi = {10.1128/msystems.01466-21},
}
Figure